Yu John S 4
4 · Kairos Pharma, LTD. · Filed Nov 21, 2024
Insider Transaction Report
Form 4
Yu John S
DirectorCEO and Chairman10% Owner
Transactions
- Purchase
COMMON STOCK
2024-11-20$1.44/sh+4,000$5,760→ 5,341,837 total
4 · Kairos Pharma, LTD. · Filed Nov 21, 2024
COMMON STOCK